China's State FDA Freezes Sale And Production Of Dextropropoxyphene Drugs
This article was originally published in PharmAsia News
Executive Summary
China's State FDA recently ordered a halt on the manufacture, sale and use of dextropropoxyphene drugs and a recall of the products beginning July 31